Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Qualigen Therapeutics, Inc. (QLGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5220-0.0477 (-8.37%)
At close: 04:00PM EDT
0.5510 +0.03 (+5.56%)
After hours: 07:23PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
3/31/2020
Total Revenue
4,476
5,654
5,558
Cost of Revenue
3,959
4,332
3,978
Gross Profit
517.404
1,321
1,580
Operating Expense
22,376
23,984
3,083
Operating Income
-21,859
-22,663
-1,503
Net Non Operating Interest Income Expense
31.659
42.693
-283.095
Other Income Expense
3,288
4,729
2.785
Pretax Income
-18,539
-17,892
-1,784
Tax Provision
5.633
5.427
4
Net Income Common Stockholders
-18,544
-17,897
-1,788
Diluted NI Available to Com Stockholders
-18,544
-17,897
-1,788
Basic EPS
-
-0.61
-0.14
Diluted EPS
-
-0.61
-0.14
Basic Average Shares
-
29,335
12,540
Diluted Average Shares
-
29,335
12,540
Total Operating Income as Reported
-21,859
-22,663
-1,503
Total Expenses
26,335
28,317
7,061
Net Income from Continuing & Discontinued Operation
-18,544
-17,897
-1,788
Normalized Income
-20,514
-21,345
-1,788
Interest Expense
-
-
283.095
Net Interest Income
31.659
42.693
-283.095
EBIT
-21,859
-22,663
-1,500
EBITDA
-21,518
-
-
Reconciled Cost of Revenue
3,959
4,332
3,978
Reconciled Depreciation
340.889
338.277
216.602
Net Income from Continuing Operation Net Minority Interest
-18,544
-17,897
-1,788
Total Unusual Items Excluding Goodwill
3,284
4,723
0
Total Unusual Items
3,284
4,723
0
Normalized EBITDA
-24,801
-27,048
-1,284
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
1,313
1,275
0
Advertisement
Advertisement